In a major step toward ending the global threat of meningitis, the World Health Organization (WHO) has released its first-ever global guidelines for the diagnosis, treatment, and care of meningitis disease.
According to WHO it aimed at improving early detection and boosting survival rates, the guidelines offer a comprehensive, evidence-based framework to reduce the devastating toll of meningitis—particularly in low- and middle-income countries, where the burden remains highest.
Despite the existence of effective treatments and vaccines for some forms of meningitis, the disease continues to claim hundreds of thousands of lives each year.
Bacterial meningitis—the deadliest form—can kill within 24 hours and often leaves survivors with long-term disabilities.
In 2019 alone, an estimated 2.5 million cases were reported globally, including 1.6 million bacterial meningitis cases that resulted in approximately 240,000 deaths.
“Bacterial meningitis kills one in six of the people it strikes and leaves many others with lasting health challenges,” said WHO Director-General Dr. Tedros Adhanom Ghebreyesus. “Implementing these new guidelines will help save lives, improve long-term care for those affected by meningitis, and strengthen health systems.”
Read Also: WHO warns of disease outbreak
The new guidelines are the first global standard focused specifically on improving clinical care for children over one month of age, adolescents, and adults affected by acute community-acquired meningitis.
They provide health professionals with clear recommendations on diagnosis, antibiotic therapy, adjunctive treatments, supportive care, and the management of long-term complications.
Given that meningitis symptoms often mimic those of other diseases, timely diagnosis and treatment are critical.
The WHO guidelines take this into account, offering strategies for both bacterial and viral causes of the disease.
Special emphasis is placed on equipping healthcare workers in first- and second-level facilities—including emergency rooms and outpatient clinics—with the tools they need to act fast.
The guidelines replace WHO’s 2014 epidemic response protocols and now include detailed recommendations for both non-epidemic and epidemic scenarios.
Developed with the realities of resource-limited settings in mind, the guidelines aim to be practical, scalable, and applicable in countries with the highest disease burden—particularly in Africa’s “meningitis belt,” a region prone to recurring outbreaks.
Beyond clinical care, the guidelines contribute directly to the WHO’s broader Defeating Meningitis by 2030 Global Roadmap.
Adopted by member states in 2020, the roadmap sets bold targets: eliminating bacterial meningitis epidemics, reducing vaccine-preventable cases by half, cutting deaths by 70%, and improving quality of life for survivors.
WHO highlighted that early detection, treatment, vaccine affordability, disease surveillance, care and support, advocacy, along with engagement, will aid in achieving the goals of curbing and preventing the strong strain of this deadly disease globally.
However, policymakers, academic institutions, civil society organizations, and frontline health workers are encouraged to use the guidelines as a resource for building capacity, informing national health plans, and shaping research agendas.
